126 results
424B3
KBLB
Kraig Biocraft Laboratories, Inc
16 Nov 23
Prospectus supplement
4:30pm
Operating Expenses
General and Administrative
Professional Fees
Officer’s Salary
Research and Development
Total Operating Expenses
Loss from …
Gross unrealized gain
Fair value
December 31, 2022
Treasury Bills – Redemption
Total Investments, September 30, 2023
Research and Development Costs
424B3
KBLB
Kraig Biocraft Laboratories, Inc
11 Sep 23
Prospectus supplement
4:30pm
, luxury fashion, flexible composites, medical implants, cosmetics and more. We believe that we have been a leader in the research and development … will be profitable. We expect to incur significant research and development costs for the foreseeable future. We may not be able to successfully market fiber
POS AM
qymmmm7dkx3182iaahvf
1 Sep 23
Prospectus update (post-effective amendment)
4:30pm
424B3
oc1xp9v
18 May 23
Prospectus supplement
4:31pm
POS AM
xiezhx7
14 Apr 23
Prospectus update (post-effective amendment)
4:59pm
424B3
02yjqxonkh 7ennaf3r
17 Nov 22
Prospectus supplement
1:19pm
424B3
8ckic
12 Aug 22
Prospectus supplement
4:30pm